Ciliary Body and Choroid Melanoma, Medium/Large Size Completed Phase 2 Trials for Aflibercept (DB08885)

IndicationStatusPhase
DBCOND0030825 (Ciliary Body and Choroid Melanoma, Medium/Large Size)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00450255VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryTreatment